DXA data from the STEP-1 and SURMOUNT-1 trials show meaningful lean mass reduction during GLP-1-driven weight loss: approximately 9.7% of total lean tissue with semaglutide in STEP-1, and 10.9% with tirzepatide in SURMOUNT-1
Frequently Asked Questions Is Gimme Care a legitimate telehealth company or a scam
Plasma AUC and pharmacokinetic parameters (C max , T max , t 1/2) for TMAO, L-carnitine, and -BB were assessed following OCC with pomegranate extract (1.6 g) or placebo
Glucagon-like Peptide-1 Receptor Agonist
Encapsulated PDRN and glutathione help deliver active ingredients effectively, supporting smoother, brighter-looking skin
In-clinic, youll receive an injection (often in the arm or buttock) administered safely by trained staff